Published in Am J Med on June 01, 1968
Mechanism of thyroid calorigenesis: role of active sodium transport. Proc Natl Acad Sci U S A (1970) 1.61
Stimulation of mitochondrial adenosine diphosphate uptake by thyroid hormones. Proc Natl Acad Sci U S A (1973) 1.07
Mechanochemistry of cardiac muscle. V. Influence of thyroid state on energy utilization. J Clin Invest (1971) 0.83
Malignant hyperthermia--an investigation of three patients. Ann R Coll Surg Engl (1971) 0.75
Thyrotoxic myopathy. Pathomorphological observations of human material and experimentally induced thyrotoxicosis in rats. Acta Neuropathol (1981) 0.75
Procedure for the histochemical demonstration of actomyosin ATPase. Exp Neurol (1970) 3.54
Qualitative differences between actomyosin ATPase of slow and fast mammalian muscle. Exp Neurol (1969) 2.81
Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab (1967) 2.47
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med (1997) 2.20
Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing. Thyroid (1996) 2.05
CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol (2000) 1.99
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A (1989) 1.85
Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab (1985) 1.69
The morning-report syndrome and medical search. N Engl J Med (1979) 1.53
CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1995) 1.49
Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab (1995) 1.46
Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med (1982) 1.46
Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab (1992) 1.40
Immunosuppression of thyroiditis. Endocrinology (1996) 1.39
Inclusion body myositis. Lab Invest (1971) 1.39
Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide: clinical, pathological, kinetic, and biochemical studies and a review of the literature. J Clin Endocrinol Metab (1981) 1.36
Characterization of a thyroid hormone receptor expressed in human kidney and other tissues. Proc Natl Acad Sci U S A (1988) 1.33
Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. Mol Endocrinol (1990) 1.26
Serum pyruvate kinase in muscle disease and carrier states. Neurology (1974) 1.23
Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease. N Engl J Med (1984) 1.18
Erroneous interpretations which may result from application of the "myofibrillar ATPase" histochemical procedure to developing muscle. Exp Neurol (1972) 1.18
Characterization of a third human thyroid hormone receptor coexpressed with other thyroid hormone receptors in several tissues. Mol Endocrinol (1988) 1.16
Studies on suppressor cell function in thyroid diseases. J Clin Endocrinol Metab (1979) 1.16
Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. J Clin Endocrinol Metab (1994) 1.15
Decreased suppressor T-lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab (1982) 1.15
Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone. Metabolism (1972) 1.10
A human early response gene homologous to murine nur77 and rat NGFI-B, and related to the nuclear receptor superfamily. Mol Endocrinol (1990) 1.10
Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab (1979) 1.09
Triiodothyronine binding to isolated liver cell nuclei. Endocrinology (1975) 1.08
Retrospective and prospective study of radiation-induced thyroid disease. Am J Med (1983) 1.08
Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab (1994) 1.08
Binding of T3 in rat liver nuclei. Endocrinology (1974) 1.06
Identification of a thyroid microsomal antigen by Western blot and immunoprecipitation. J Clin Endocrinol Metab (1985) 1.06
Triiodothyronine binding to liver nuclear solubilized proteins in vitro. Endocrinology (1975) 1.06
Function changes in spinal muscular atrophy II and III. The DCN/SMA Group. Neurology (1996) 1.05
Regulation of cardiac sarcoplasmic reticulum calcium transport by calcium-calmodulin-dependent phosphorylation. J Biol Chem (1983) 1.04
Kinetic analysis of iodine metabolism. J Clin Endocrinol Metab (1966) 1.04
Differences between slow and fast muscle myosin. Adenosine triphosphatase activity and release of associated proteins by p-chloromercuriphenylsulfonate. J Biol Chem (1970) 1.04
Reye's syndrome:clinical diagnosis and treatment with peritoneal dialysis. Pediatrics (1974) 1.04
Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. J Child Neurol (2000) 1.03
Biochemical abnormalities of the sarcoplasmic reticulum in muscular dystrophy. N Engl J Med (1969) 1.03
Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the gene for thyroid peroxidase. J Clin Invest (1987) 1.02
The neural regulation of gene expression in the muscle cell. Exp Neurol (1970) 1.02
Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab (1994) 1.02
High affinity and specificity of dimeric binding of thyroid hormone receptors to DNA and their ligand-dependent dissociation. Mol Endocrinol (1993) 1.01
Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1993) 1.01
Structural analysis of human thyroid hormone receptor beta gene. Mol Cell Endocrinol (1990) 0.99
Molecular cloning of the complementary deoxyribonucleic acid for human thyroid peroxidase. Mol Endocrinol (1987) 0.99
Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action. J Clin Endocrinol Metab (1978) 0.99
A nomenclature for tests of thyroid hormones in serum: report of a committee of the American Thyroid Association. J Clin Endocrinol Metab (1972) 0.98
Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation. J Clin Invest (1991) 0.98
Study of circulating immune complexes in thyroid diseases: comparison of Raji cell radioimmunoassay and specific thyroglobulin-antithyroglobulin radioassay. J Clin Endocrinol Metab (1979) 0.97
Treatment of Graves' disease and the course of ophthalmopathy. Am J Med (1989) 0.97
Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab (2000) 0.96
Hürthle cell tumors: a twenty-five-year experience. Surgery (1986) 0.96
The neural regulation of some phenotypic differences between the fiber types of mammalian skeletal muscle. Exp Neurol (1970) 0.95
The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev (1991) 0.95
Antibodies against denatured and reduced thyroid microsomal antigen in autoimmune thyroid disease. J Clin Endocrinol Metab (1987) 0.92
Phenotypic differences between the actomyosin ATPase of the three fiber types of mammalian skeletal muscle. Exp Neurol (1970) 0.92
Inherited disorders of thyroid metabolism. Endocr Rev (1983) 0.91
Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease. J Clin Endocrinol Metab (1988) 0.91
Serum thyroglobulin in the management of patients with thyroid cancer. Arch Intern Med (1982) 0.91
Remission of myasthenia and thyrotoxicosis after thymectomy. Ann Intern Med (1967) 0.91
Characterization of nuclear thyroid hormone receptors of cultured skin fibroblasts from patients with resistance to thyroid hormone. Metabolism (1987) 0.91
Duchenne muscular dystrophy: adenosine triphosphate and creatine phosphate content in muscle. Neurology (1981) 0.90
Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: reduced T-suppressor cell activity in Graves' disease. Clin Endocrinol (Oxf) (1983) 0.89
Human lymphotoxin obtained from established lymphoid lines: purification characteristics and inhibition by anti-immunoglobulin. J Immunol (1974) 0.89
Expression of three forms of thyroid hormone receptor in human tissues. Mol Endocrinol (1989) 0.89
Effect of stable iodine on thyroid iodine release. J Clin Endocrinol Metab (1969) 0.89
Diurnal rhythm in total serum thyroxine levels. Metabolism (1971) 0.89
Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor. Endocrinology (1995) 0.88
Observations on the role of circulating lymphocytes in thyroid auto-immunity. J Clin Endocrinol Metab (1969) 0.88
Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab (1997) 0.87
Management of myasthenia gravis by extended thymectomy with anterior mediastinal dissection. Surgery (1992) 0.87
Prospective study of spinal muscular atrophy before age 6 years. DCN/SMA Group. Pediatr Neurol (1993) 0.87
Dinucleotide repeat polymorphism in the human thyroid hormone receptor beta gene (THRB) on chromosome 3. Nucleic Acids Res (1991) 0.87
Studies on myotonia. Biochemical and electron microscopic studies on myotonia congenita and myotonia dystrophica. Arch Neurol (1967) 0.87
N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery (1994) 0.87
Genetic linkage studies of thyroid peroxidase (TPO) gene in families with TPO deficiency. J Clin Endocrinol Metab (1991) 0.86
Vitiligo in Graves' disease. Ann Intern Med (1969) 0.86
Thyroid carcinoma. Med Clin North Am (1975) 0.86
Cloning and characterization of the human thyroid hormone receptor beta 1 gene promoter. Biochem Biophys Res Commun (1992) 0.86
Antipeptide polyclonal antibodies specifically recognize each human thyroid hormone receptor isoform. Endocrinology (1992) 0.86
Peroxidase deficiency in familial goiter with iodide organification defect. N Engl J Med (1971) 0.85
Low-dose sodium iodide I 131 therapy in Graves disease. JAMA (1973) 0.85
Nuclear thyroid hormone receptors in cultured human fibroblasts: improved method of isolation, partial characterization, and interaction with chromatin. Metabolism (1986) 0.85
Reduced nuclear triiodothyronine receptors in starvation-induced hypothyroidism. Biochem Biophys Res Commun (1977) 0.85
Peroxidase defect in congenital goiter with complete organification block. J Clin Endocrinol Metab (1973) 0.85
Thyroid and the heart. Mayo Clin Proc (1972) 0.84
Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 0.84
Myosin light chains in Duchenne dystrophy and paraplegic muscle. Neurology (1979) 0.84
Studies on the Na+- and K+ -activated adenosine triphosphatase in human striated muscle. Arch Biochem Biophys (1966) 0.84
Peroxidase and NADPH-cytochrome C reductase activity during thyroid hyperplasia and involution. Endocrinology (1974) 0.84
A new solid-phase radioimmunoassay to measure IgG secreted by cultured human lymphocytes. J Immunol Methods (1980) 0.84
Action of potassium iodide on thyroxine metabolism. J Clin Endocrinol Metab (1966) 0.83
Studies on thyroglobulin-specific suppressor T cell function in autoimmune thyroid disease. J Clin Endocrinol Metab (1985) 0.83
HLA class II associations in African-American female patients with Graves' disease. Thyroid (1996) 0.83
The dominant negative effect of thyroid hormone receptor splicing variant alpha 2 does not require binding to a thyroid response element. Mol Endocrinol (1995) 0.83